Kansas City, Missouri 64111


The purpose of this study is to study the role of the Immune System in causing arthritis in patients with Hepatitis C.

Study summary:

Patients will provide one blood sample after qualifying for the study, and signing consent. The patients will have a skin test TB, Candida, and Trichophyton placed and will read the results themselves and mail back the card with the measurements to be recorded. Labs will test for ESR, CBC, CRP, antiCCP, Cryoglobulins, RF, CH50, C3, C4, Flow cytometry, and would have already been tested for HIV and Hepatitis C.


Inclusion Criteria: - All adults 18 or older, 20 will have hep C positive with a viral load withen 6 mo. of enrollment. - Either interferon or antiviral naive or those who failed interferon or antiviral therapy more than 6 mo. prior to enrollment. - 10 normal healthy controls- Hep C neg and without osteoarthritis (OA). Exclusion Criteria: - HIV patients - Those with concomitant alcoholic liver disease - Patients with Rheumatoid Arthritis (RA) or other autoimmune disorders.



Primary Contact:

Principal Investigator
Nabih I Abdou, MD, PhD
Center for Rheumatic Disease, Allergy & Immunology

Nabih I Abdou, MD, PhD
Phone: 816-531-0930

Backup Contact:

Email: cindy@centerforrheumatic.com
Cindy A Greenwell, RN, BSN, CCRC
Phone: 816-531-0930

Location Contact:

Kansas City, Missouri 64111
United States

Cindy A Greenwell, MD, PHD
Phone: 816-531-0930
Email: cindy@centerforrheumatic.com

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.